You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Atrial natriuretic factor.

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fluid Overload, Fluid Loss, Volume Overload Trial in Moscow (pro-ANP)

Completed
  • Fluid Overload
  • +5 more
  • pro-ANP
  • Moscow, Russian Federation
    Petrovsky Research National Centre of Surgery (Petrovsky NRCS)
Sep 27, 2022

Atrial Fibrillation, Anticoagulant-induced Bleeding Trial in Seoul (Factor Xa Inhibitor)

Recruiting
  • Atrial Fibrillation
  • Anticoagulant-induced Bleeding
  • Factor Xa Inhibitor
  • Seoul, Jongno-gu, Korea, Republic of
    Seoul National university Hostpital
Apr 5, 2023

Impact of Left Atrial Appendage Closure on Physical Capacity.

Recruiting
  • Atrial Fibrillation
    • Jena, Germany
      University of Jena
    Nov 16, 2021

    Atrial Remodeling, Myocardial Dysfunction, Left Ventricular Remodeling Trial in Dun Laoghaire, Dublin (Sacubitril-Valsartan,

    Active, not recruiting
    • Atrial Remodeling
    • +8 more
    • Dun Laoghaire, Co Dublin, Ireland
    • +1 more
    May 10, 2021

    Atrial Fibrillation Trial in Cleveland (Metformin, Lifestyle/Risk Factor Modification)

    Recruiting
    • Atrial Fibrillation
    • Cleveland, Ohio
      Cleveland Clinic
    Dec 4, 2021

    Cardiovascular Risk Factor Trial in Vienna (Levosimendan, Placebo)

    Recruiting
    • Cardiovascular Risk Factor
    • Vienna, Austria
      Medical University of Vienna
    Aug 16, 2022

    Acute Kidney Injury Trial in Gothenburg (ANP, Placebo)

    Completed
    • Acute Kidney Injury
    • Gothenburg, Sweden
      Sahlgrenska sjukhuset
    Feb 8, 2022

    Circulating BDNF in Atrial Fibrillation Undergoing Catheter

    Recruiting
    • Atrial Fibrillation
    • Catheter ablation
    • Exercise training
    • Ottawa, Ontario, Canada
      University of Ottawa Heart Institute
    Nov 18, 2021

    Atrial Fibrillation Trial in Halifax (Aggressive Risk Factor Control, Standard of Care)

    Recruiting
    • Atrial Fibrillation
    • Aggressive Risk Factor Control
    • Standard of Care
    • Halifax, Nova Scotia, Canada
      QE II Health Sciences Centre
    Jul 26, 2021

    Atrial Fibrillation, Overweight and Obesity Trial (Semaglutide Injectable Product, Placebo)

    Not yet recruiting
    • Atrial Fibrillation
    • Overweight and Obesity
    • Semaglutide Injectable Product
    • Placebo
    • (no location specified)
    Apr 25, 2022

    Atrial Fibrillation, Risk Reduction, Nurse's Role Trial in Eindhoven (Comprehensive risk factor treatment, Standard of care)

    Recruiting
    • Atrial Fibrillation
    • +2 more
    • Comprehensive risk factor treatment
    • Standard of care
    • Eindhoven, Netherlands
      Catharina Ziekenhuis
    Jan 19, 2022

    Carotid Atherosclerosis Trial in Saint Louis (Cu[64]-25%-CANF-Comb PET-MR)

    Completed
    • Carotid Atherosclerosis
    • Cu[64]-25%-CANF-Comb PET-MR
    • Saint Louis, Missouri
      Washington University in St.Louis
    Oct 13, 2022

    CANF-Comb-II PET-MR in Atherosclerosis Multisite

    Recruiting
    • Carotid Atherosclerosis
    • +2 more
    • Los Angeles, California
    • +1 more
    Apr 27, 2023

    Heparin Requirements in Patients Undergoing Atrial Fibrillation

    Completed
    • Atrial Fibrillation
    • Monitoring Anti Factor Xa level
    • Brighton, Massachusetts
      St Elizabeth Medical Center
    Jul 15, 2021

    Atrial Fibrillation Trial in Hellerup (Colchicine, Placebo)

    Not yet recruiting
    • Atrial Fibrillation
    • Hellerup, Denmark
      Center for Translational Cardiology and Pragmatic Randomized Tri
    Jun 23, 2023

    Covid19, Comorbidities and Coexisting Conditions, Risk Factor, Cardiovascular Trial in Moscow

    Completed
    • Covid19
    • +8 more
      • Moscow, Russian Federation
        Eurasian Association of Therapists
      Feb 1, 2022

      Chronic Coronary Syndrome, Atrial Fibrillation Trial (Dapagliflozin 10mg Tab, Placebo Tab)

      Not yet recruiting
      • Chronic Coronary Syndrome
      • Atrial Fibrillation
      • Dapagliflozin 10mg Tab
      • Placebo Tab
      • (no location specified)
      May 9, 2023

      Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral

      Completed
      • Atrial Fibrillation
      • Multiple Locations, Germany
        Many Locations
      Nov 24, 2020

      Fabry Disease Trial in Roma (Sample blood and 2D-echocardiography with Doppler)

      Recruiting
      • Fabry Disease
      • Sample blood and 2D-echocardiography with Doppler
      • Roma, Italy
        Fondazione Policlinico Gemelli
      Feb 27, 2023

      Recurrent Atrial Fibrillation, Persistent Atrial Fibrillation Trial in Czechia (Atrioventricular junction ablation in patients

      Not yet recruiting
      • Recurrent Atrial Fibrillation
      • Persistent Atrial Fibrillation
      • Atrioventricular junction ablation in patients with cardiac resynchronization therapy (CRT)
      • Optimal medication treatment in patients with cardiac resynchronization therapy (CRT)
      • Liberec, Liberec Region, Czechia
      • +8 more
      Mar 17, 2023

      Blood Pressure, Anesthesia Trial in Gothenburg (Norepinephrine, Maintained blood pressure)

      Completed
      • Blood Pressure
      • Anesthesia
      • Gothenburg, Sweden
        Sahlgrenska University Hospital
      Apr 28, 2020

      ISOLATION 2.0: a Multicenter Clinical Care and Research Platform

      Not yet recruiting
      • Atrial Fibrillation
        • (no location specified)
        May 18, 2022

        Fluid Overload, Dialysis; Complications Trial in Umea (Ultrafiltration rate)

        Recruiting
        • Fluid Overload
        • Dialysis; Complications
        • Ultrafiltration rate
        • Umea, Sweden
          Region Vasterbotten, Norrlands Universitetssjukhus, Dialysen
        Nov 22, 2023

        Cardiac Injury With Convulsive Status Epilepticus

        Not yet recruiting
        • Convulsive Status EPILEPTICUS
          • (no location specified)
          Nov 5, 2023

          Hypopituitarism Trial in Torino (Intravenous Infusion of Diclofenac Sodium, Intravenous Infusion of Placebo)

          Completed
          • Hypopituitarism
          • Intravenous Infusion of Diclofenac Sodium
          • Intravenous Infusion of Placebo
          • Torino, Piemonte, Italy
            AOU Città della Salute e della Scienza
          Jan 11, 2022